Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells

Experimental Cell Research

Volumn 256, Issue 2, 2000, Pages 563-570

  Hsi, Linda C ^a   Joon Baek, Seung ^a   Eling, Thomas E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; CARCINOMA CELL; CATALYSIS; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; ENZYME ACTIVITY; ENZYME INDUCTION; GENE MUTATION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; INTESTINE CELL; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0343527280     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4863     Document Type: Article

References (37)

1. Smith W. L., DeWitt D. L. Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol. 62:1996;167-215.
2. Herschman H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299:1996;125-140.
3. Fletcher B. S., Kujubu D. A., Perrin D. M., Herschman H. R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:1992;4338-4344.
4. Sano H., Kawahito K., Wilder R. L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
5. Kargman S. L., O'Neill G. P., Vickers P. J., Evans J. F., Mancini J. A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
6. Kutchera W., Jones D. A., Matsunami N., Groden J., McIntyre T. M., Zimmerman G. A., White R. L., Prescott S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA. 93:1996;4816-4820.
7. Eberhart G. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., Dubois R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinoma. Gastroenterology. 107:1994;1183-1188.
8. Bennett A., del Tacca M. Proceedings: Prostaglandins in human colonic carcinoma. Gut. 16:1975;409.
9. Jaffe B. M. Prostaglandins and cancer: An update. Prostaglandins. 6:1974;453-461.
10. Bennett A., Tacca M. D., Stamford I. F., Zebro T. Prostaglandins from tumours of human large bowel. Br. J. Cancer. 35:1977;881-884.
11. Taketo M. M. Cyclooxygenase-2 inhibitors in tumorigenesis. Part II. J. Natl. Cancer Inst. 90:1998;1609-1620.
12. DuBois R. N., Radhika A., Reddy B. S., Entingh A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1996;1259-1262.
13. Williams C. W., Luongo C., Radhika A., Zhang T., Lamps L. W., Nanney L. B., Beauchamp R. D., DuBois R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology. 110:1996;1134-1140.
14. Δ716 knockout mice by inhibition of cyclooxygenase 2. Cell. 87:1996;803-809.
15. Tsujii M., DuBois R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.
16. Morin P. J., Vogelstein B., Kinzler K. W. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA. 93:1996;7950-7954.
17. Hsi L. C., Angerman-Stewart J., Eling T. E. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis. 20:1999;2045-2049.
18. Henke D. C., Kouzan S., Eling T. E. Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. Anal. Biochem. 140:1984;87-94.
19. 14C]-arachidonic acid by human colonic mucosa. Gut. 24:1985;1176-1182.
20. Kamitani H., Geller M., Eling T. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem. 273:1998;21569-21577.
21. 2 in human colon cancer cells. Cancer Res. 58:1998;362-366.
22. Smith W. L., Eling T. E., Kulmacz R. J., Marnett L. J., Tsai A. Tyrosyl radicals and their role in hydroperoxide-dependent activation and inactivation of prostaglandin endoperoxide synthase. Biochemistry. 31:1992;3-7.
23. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89:1992;7384-7388.
24. Ciccarone V., Chu Y., Schifferli K., Pichet J. P., Hawley-Nelson P., Evans K., Roy L., Bennett S. Lipofectamine 2000 reagent for rapid, efficient transfection of eukaryotic cells. Focus. 21:1999;54-55.
25. Shiff S. J., Qiao L., Tsai L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
26. Goldberg Y., Nassif I. I., Pittas A., Tsai L., Dynlacht B. D., Rigas B., Shiff S. J. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene. 12:1996;893-901.
27. Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245.
28. Landino L. M., Crews B. C., Timmons M. D., Morrow J. D., Marnett L. J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA. 93:1996;15069-15074.
29. Parker J., Kaplon M. K., Alvarez C. J., Krishnaswamy G. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp. Cell Res. 236:1997;321-329.
30. Meade E. A., McIntyre T. M., Zimmerman G. A., Prescott S. M. Proxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem. 274:1999;8328-8334.
31. Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 265:1994;956-959.
32. Levy G. N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
33. Lehmann J. M., Lenhard J. M., Oliver B. B., Ringold G. M., Kliewer S. A. Proxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
34. Spiegelman B. M., Flier J. S. Adipogenesis and obesity: Rounding out the big picture. Cell. 87:1996;377-389.
35. Sarrif P., Mueller E., Jones D., King F. J., DeAngelo D. J., Partridge J. B., Holden S. A., Chen L. B., Singer S., Fletcher C., Spiegelman B. M. Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat. Med. 4:1998;1046-1052.
36. He T. C., Chan T. A., Vogelstein B., Kinzler K. W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:1999;335-345.
37. Murphy V. J., Yang Z., Rorison K. A., Baldwin G. S. Cyclooxygnease-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines. Cancer Lett. 122:1998;25-30.